Velphoro (vel-FOUR-oh, sucroferric oxyhydroxide) is a new med for patients with kidney disease and high phosphate blood levels
April 2014
Velphoro (vel-FOUR-oh, sucroferric oxyhydroxide) is a new med for patients with kidney disease and high phosphate blood levels.
Think of it as similar to Renagel (sevelamer hydrochloride), Renvela (sevelamer carbonate), or Fosrenol (lanthanum carbonate).
They all bind to phosphate in the gut to lower phosphate blood levels in patients with chronic kidney disease. And they're calcium-free, so they can be used in patients who also have high calcium blood levels.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote